Ignite Creation Date:
2024-07-17 @ 11:27 AM
Last Modification Date:
2024-10-26 @ 3:33 PM
Study NCT ID:
NCT06479863
Status:
RECRUITING
Last Update Posted:
2024-06-28
First Post:
2024-05-24
Brief Title:
Efficacy and Safety of Pozelimab and Cemdisiran Combination Therapy in Patients With Sporadic Inclusion Body Myositis
Sponsor:
Austin Neuromuscular Center
Organization:
Austin Neuromuscular Center
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Sporadic Inclusion Body Myositis sIBM |
| Idiopathic Inflammatory Myopathies |
Keywords: